Teva Pharmaceutical Industries (TEVA) EV to EBITDA (2009 - 2026)
Teva Pharmaceutical Industries' (TEVA) EV to EBITDA stood at 13.82 in Q2 2026, up 55.2% from 8.91 a year earlier and up 45.0% from the prior quarter.
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EV to EBITDA (2009 - 2026) Analysis & Trends
On a TTM basis, Teva Pharmaceutical Industries' EV to EBITDA came in at 10.16 as of Jun 30, 2026, up 122.4% year-over-year; for FY2025, it came in at 11.72, down 62.3% from FY2024.
- Across earlier years, EV to EBITDA came in at 31.07 in FY2024 (+396.6%), 6.26 in FY2023 and 2.76 in FY2021.
- The Q2 2026 figure is the highest quarterly EV to EBITDA since Q4 2024.
- On a year-over-year basis, EV to EBITDA rose in four of the last seven quarters, with growth averaging 51.4%.
- Peak year-over-year performance for EV to EBITDA in the last five years was growth of 563.2% in Q2 2023, against a decline of 93.8% in Q2 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 9.53 (Q1 2026), 11.72 (Q4 2025) and 7.39 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Teva Pharmaceutical Industries | 45.31 Bn | 32.16 Bn | 2.15 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.82 |
| Mar 31, 2026 | 9.53 |
| Dec 31, 2025 | 11.72 |
| Sep 30, 2025 | 7.39 |
| Jun 30, 2025 | 8.91 |
| Mar 31, 2025 | 10.88 |
| Dec 31, 2024 | 31.07 |
| Sep 30, 2024 | 11.32 |
| Jun 30, 2024 | 8.36 |
| Mar 31, 2024 | 9.83 |
| Dec 31, 2023 | 6.26 |
| Jun 30, 2023 | 133.86 |
| Sep 30, 2022 | 52.01 |
| Jun 30, 2022 | 20.18 |
| Mar 31, 2022 | 4.96 |
| Dec 31, 2021 | 2.76 |
| Sep 30, 2021 | 2.81 |
| Jun 30, 2020 | 5.92 |
| Mar 31, 2020 | 7.04 |
| Dec 31, 2019 | 8.50 |
API Access
Teva Pharmaceutical Industries EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TEVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "TEVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=TEVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();